IRCT20190325043107N40
Completed
Phase 2
Comparison of intranasal administration with intravenous injection of dexmedetomidine in postoperative pain control of mandibular fractures
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Pain intensity.
- Sponsor
- Tabriz University of Medical Sciences
- Enrollment
- 70
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients with ASA class I, II
- •candidate for mandibular fracture surgery
- •Consent to participate in this research project
Exclusion Criteria
- •Patients with a history of high blood pressure
- •Patients taking antihypertensive drugs
- •Patients taking beta blockers
- •Patients with a history of heart disease
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 2
Effect of midazolam through nasal versus intravenous route in controlling seizures in children.Health Condition 1: G969- Disorder of central nervous system, unspecifiedCTRI/2024/01/061644Government medical college and hospital, Chandigarh
Recruiting
Phase 3
A clinical trial to study the effects of nasal and venous dexmetomidine on change of blood pressure and heart rate during anaesthesia in lumber spine surgeryHealth Condition 1: null- elective lumber spine surgery.CTRI/2018/03/012556Bangur Institute of Neurosciences
Not yet recruiting
Phase 3
The study the effect of intranasal and intravenous dexmeditomidineHealth Condition 1: O- Medical and SurgicalCTRI/2023/09/057760Vardhman Mahavir Medical College New Delhi
Not yet recruiting
Not Applicable
Comparison of Ease of Administration of nasal Midazolam Spray and Midazolam Syrup by Parents to Children before SurgeryHealth Condition 1: null- Children of age 1 to 6 yrs of ASA physical status 1 and 2 undergoing elective surgical proceduresCTRI/2015/01/005449JIPMER90
Active, not recruiting
Not Applicable
Comparative efficacy and safety of two intranasal Triamcinolone Acetonide formulations in persistent allergic rhinitisPersistent allergic rhinitisEUCTR2005-002742-19-GBeolab Limited24